Antigen-specific tolerance strategies for the prevention and treatment of autoimmune disease

被引：238

作者：

Miller, Stephen D. ^{[1
]}

Turley, Danielle M. ^{[1
]}

Podojil, Joseph R. ^{[1
]}

机构：

[1] Northwestern Univ, Immunobiol Ctr, Dept Microbiol Immunol & Interdepartmental, Feinberg Sch Med, Chicago, IL 60611 USA

来源：

NATURE REVIEWS IMMUNOLOGY | 2007年 / 7卷 / 09期

关键词：

D O I：

10.1038/nri2153

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

The development of safe and effective antigen-specific therapies is needed to treat patients with autoimmune diseases. These therapies must allow for the specific tolerization of self-reactive immune cells without altering host immunity to infectious insults. Experimental models and clinical trials for the treatment of autoimmune disease have identified putative mechanisms by which antigen-specific therapies induce tolerance. Although advances have been made in the development of efficient antigen-specific therapies, translating these therapies from bench to bedside has remained difficult. Here, we discuss the recent advances in our understanding of antigen-specific therapies for the treatment of autoimmune diseases.

引用

收藏

页码：665 / 677

页数：13

相关论文

共 122 条

[81]

Nicholson LB, 1997, CRIT REV IMMUNOL, V17, P449

[82] A T cell receptor antagonist peptide induces T cells that mediate bystander suppression and prevent autoimmune encephalomyelitis induced with multiple myelin antigens [J].

Nicholson, LB ;

Murtaza, A ;

Hafler, BP ;

Sette, A ;

Kuchroo, VK .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (17) :9279-9284

[83] AN ALTERED PEPTIDE LIGAND MEDIATES IMMUNE DEVIATION AND PREVENTS AUTOIMMUNE ENCEPHALOMYELITIS [J].

NICHOLSON, LB ;

GREER, JM ;

SOBEL, RA ;

LEES, MB ;

KUCHROO, VK .

IMMUNITY, 1995, 3 (04) :397-405

[84] The many important facets of T-cell repertoire diversity [J].

Nikolich-Zugich, J ;

Slifka, MK ;

Messaoudi, I .

NATURE REVIEWS IMMUNOLOGY, 2004, 4 (02) :123-132

[85] T-cell signalling and autoimmunity: Molecular mechanisms of disease [J].

Ohashi, PS .

NATURE REVIEWS IMMUNOLOGY, 2002, 2 (06) :427-438

[86] An unexpected version of horror autotoxicus: anaphylactic shock to a self peptide [J].

Pedotti, R ;

Mitchell, D ;

Wedemeyer, J ;

Karpuj, M ;

Chabas, D ;

Hattab, EM ;

Tsai, M ;

Galli, SJ ;

Steinman, L .

NATURE IMMUNOLOGY, 2001, 2 (03) :216-222

[87]

Pipeleers D, 2002, ANN NY ACAD SCI, V958, P69

[88] ANTIGEN-SPECIFIC INHIBITION OF THE ADOPTIVE TRANSFER OF EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS IN LEWIS RATS [J].

POPE, L ;

PATERSON, PY ;

MILLER, SD .

JOURNAL OF NEUROIMMUNOLOGY, 1992, 37 (03) :177-189

[89] No effect of oral insulin on residual beta-cell function in resent-onset Type I diabetes (the IMDIAB VII) [J].

Pozzilli, P ;

Pitocco, D ;

Visalli, N ;

Cavallo, MG ;

Buzzetti, R ;

Crinò, A ;

Spera, S ;

Suraci, C ;

Multari, G ;

Cervoni, M ;

Bitti, MLM ;

Matteoli, MC ;

Marietti, G ;

Ferrazzoli, F ;

Faldetta, MRC ;

Giordano, C ;

Sbriglia, M ;

Sarugeri, E ;

Ghirlanda, G .

DIABETOLOGIA, 2000, 43 (08) :1000-1004

[90] Epitope-specific immunotherapy induces immune deviation of proinflammatory T cells in rheumatoid arthritis [J].

Prakken, BJ ;

Samodal, R ;

Le, TD ;

Giannoni, F ;

Yung, GP ;

Scavulli, J ;

Amox, D ;

Roord, S ;

de Kleer, I ;

Bonnin, D ;

Lanza, P ;

Berry, C ;

Massa, M ;

Billetta, R ;

Albani, S .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (12) :4228-4233

← 4 5 6 7 8 9 10 11 12 13 →